Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Treatment of Ph-negative ALL in adolescents and young adults

Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain
Treatment of Ph-negative ALL in adolescents and young adults ( Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain )
23 Jan 2020

The new era of ALL treatment

Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain
The new era of ALL treatment ( Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain )
23 Jan 2020

Safety considerations for inotuzumab in patients with relapsed/refractory ALL

Prof David Marks - University Hospitals Bristol NHS Foundation Trust, Bristol, UK
Safety considerations for inotuzumab in patients with relapsed/refractory ALL ( Prof David Marks - University Hospitals Bristol NHS Foundation Trust, Bristol, UK )
23 Jan 2020

HER2CLIMB: Investigating tucatinib with capecitabine and trastuzumab in HER2-positive metastatic breast cancer

Dr Rashmi Murthy - MD Anderson Cancer Center, Houston, USA
HER2CLIMB: Investigating tucatinib with capecitabine and trastuzumab in HER2-positive metastatic breast cancer ( Dr Rashmi Murthy - MD Anderson Cancer Center, Houston, USA )
23 Jan 2020

Oral paclitaxel yields better outcomes than IV paclitaxel in metastatic breast cancer

Dr Gerardo Umanzor - Hospital del Valle, San Pedro Sula, Honduras
Oral paclitaxel yields better outcomes than IV paclitaxel in metastatic breast cancer ( Dr Gerardo Umanzor - Hospital del Valle, San Pedro Sula, Honduras )
23 Jan 2020

Novel therapeutic approaches in B-progenitor ALL

Dr Charles Mullighan - St. Jude's Children's Research Hospital, Memphis, USA
Novel therapeutic approaches in B-progenitor ALL ( Dr Charles Mullighan - St. Jude's Children's Research Hospital, Memphis, USA )
23 Jan 2020

Identifying cancer susceptibility genes in paediatric ALL

Dr Ching-Hon Pui - St Jude's Children's Research Hospital, Memphis, USA
Identifying cancer susceptibility genes in paediatric ALL ( Dr Ching-Hon Pui - St Jude's Children's Research Hospital, Memphis, USA )
23 Jan 2020

Defining high-risk acute lymphoblastic leukaemia

Dr Ching-Hon Pui - St Jude's Children's Research Hospital, Memphis, USA
Defining high-risk acute lymphoblastic leukaemia ( Dr Ching-Hon Pui - St Jude's Children's Research Hospital, Memphis, USA )
23 Jan 2020

Latest concepts in frontline therapy for paediatric ALL

Dr Ching-Hon Pui - St Jude's Children's Research Hospital, Memphis, USA
Latest concepts in frontline therapy for paediatric ALL ( Dr Ching-Hon Pui - St Jude's Children's Research Hospital, Memphis, USA )
23 Jan 2020

Improving safety for healthcare workers and patients

Philippa Jones - UKONS past Head of Acute Oncology
Improving safety for healthcare workers and patients ( Philippa Jones - UKONS past Head of Acute Oncology )
13 Jan 2020

How can we maintain emotional safety?

Lesley Howells - Maggie's at The Royal Marsden, London, UK
How can we maintain emotional safety? ( Lesley Howells - Maggie's at The Royal Marsden, London, UK )
13 Jan 2020

Enhancing nurse education and nurse-led research

Dr Louise Soanes - University College Hospital, London, UK
Enhancing nurse education and nurse-led research ( Dr Louise Soanes - University College Hospital, London, UK )
13 Jan 2020